Clinical Trial Update: Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

View source ↗

Summary

Clinical trial update providing long-term follow-up data for DTX301 in adults with late-onset Ornithine Transcarbamylase deficiency. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ornithine Transcarbamylase Deficiency

Drugs mentioned

• DTX301

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Ornithine Transcarbamylase (OTC) Deficiency | Status: ACTIVE_NOT_RECRUITING